Pilot Study of Trans-radial Superior Rectal Artery Embolisation for Treating Hemorrhoids

What this Trial Is About

This research aims to evaluate the safety and effectiveness of transarterial embolisation for treating symptomatic hemorrhoids in an elective setting. Endovascular embolisation is already common for acute bleeding hemorrhoids when surgery isnt possible or has failed. This pilot study seeks to provide evidence that this less invasive treatment can be a good alternative to conventional surgery, potentially reducing complications and costs for healthcare systems under financial pressure. Participants will undergo a day procedure called trans-radial superior rectal artery embolisation performed under local anaesthetic. The study will recruit 20 selected patients with grade II-IV hemorrhoid disease who either do not wish to have surgery or have persistent symptoms despite recent surgery. This procedure involves using fluoroscopic guidance to deliver embolisation through the radial artery, aiming to reduce symptoms by blocking blood flow to the hemorrhoids. During the study, participants will be assessed with validated symptom scoring systems and routine blood tests at the initial visit. They will be followed for 24 months after the procedure to monitor symptom changes and safety outcomes. Researchers will record procedural details, radiation dose, and contrast volume, as well as compare costs over three years. The long-term goal is to build a national registry of such procedures, with total follow-up planned for three years.

Trans-radial Superior Rectal Artery Embolisation for Haemorrhoids